Revenue of OTC pharmaceuticals in Hungary 2017-2029, by segment
The revenue from OTC pharmaceuticals is forecast to increase in Hungary over the upcoming years, peaking at nearly 578 million U.S. dollars in 2029. Analgesics alongside vitamins and minerals will continue to generate a significant share of the revenue.
Find further statistics on other topics such as a comparison of the revenue in Australia & Oceania and a comparison of countries or regions regarding the revenue.
The Statista Market Insights cover a broad range of additional markets.